This Week in Psychedelics - 3.18.22

Cannabis

• Israeli Town of Tira Founds First Medical Cannabis Cafe (High Times)

• Kentucky House Passes Medical Marijuana Legalization Bill (Marijuana Moment)

• Delaware House Shoots Down Recreational Legalization Bill (High Times)

• New VA Veteran Suicide Program Won’t Allow Cannabis as Treatment (High Times)

• Mike Tyson's cannabis brand is making ear-shaped weed gummies (NBC News)

• Marijuana Legalization Hasn’t Led To More Youth Use, Report From Alcohol And Tobacco Industry-Backed Group Says (Marijuana Moment)

• Oklahoma Thieves Impersonate Cops and Raid Several Pot Farms (High Times)

• Alabama Bill Would Force Women Who Want Medical Marijuana To Show Negative Pregnancy Tests (Marijuana Moment)

• Montana Supreme Court OKs Temporary Rules For Cannabis Expungement (High Times)

• New Orleans City Council Urges End To Marijuana Testing For Government Employees (Marijuana Moment)

• Georgia Lawmakers Consider Separate Medical Cannabis Production Bills (High Times)

• Some Mississippi Cities Move To Ban Medical Marijuana Businesses (Marijuana Moment)

• European Commission Sets Standards for Hemp Food (High Times)

• Jones Soda Company Announces Cannabis-Infused Product Line (High Times)

LSD

• Montreal researchers find that, like Prozac, LSD may be useful for anxiety treatment (CTV News)

• Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety (BioSpace)

Magic Mushrooms

• California Activists Drop 2022 Psilocybin Legalization Ballot Initiative After Falling Short Of Signature Requirement (Marijuana Moment)

• Little evidence on how psilocybin therapy interacts with existing psychiatric treatments, review finds (OHSU News)

• California Psychedelics Investors Are Closely Monitoring Oregon’s Psilocybin Market (Willamette Week)

• Washington State Legislature Approves $200,000 In Psilocybin Research Funding In Budget (Marijuana Moment)

• Novamind announces phase 2 trial examining psilocybin for MDD (Healio)

• Psilocybin Is The Most Studied Psychedelic (Green Market Report)

MDMA

• MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests (PsyPost)

• Dose-ranging study provides insight into MDMA’s effects on memory, addiction, and depression (PsyPost)

Ayahuasca

• Federal judge dismisses ayahuasca church’s request for overturn of DEA decision (WFTV)

• Study will investigate ayahuasca to overcome prolonged grief (Ruetir)

• Controversy Over Injustice Against Ayahuasca Traditional Knowledge Rebounds (Chacruna)

Ketamine

• A Ketamine Clinic Treads the Line Between Health Care and a ‘Spa Day for Your Brain’ (The New York Times)

Miscellaneous

• Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy (Marijuana Moment)

• Students Launch Bid to Decriminalize All Drugs in Ann Arbor, Michigan (Filter)

• New Research Explores Whether Therapeutic Psychedelics Can Fix ‘Biophobia’ (Forbes)

• Keywords from hallucinogenic experiences can help find parts of the brain affected by drugs (The Verge)

• Feds Reveal Which Industries Drug Test Workers The Most And Least In New Report (Marijuana Moment)

• MDMA use drops due to COVID lockdowns, other drugs rise -EU report (Reuters)

• What do psychedelic drugs do to our brains? AI could help us find out (MIT Technology Review)

• How Can We Apply Harm Reduction to HPPD? (Psychedelics Today)

• Colorado Activists Pick One Of Several Psychedelics Reform Initiatives To Pursue For November Ballot (Marijuana Moment)

• London should pilot drug checking and consumption rooms, says report (London Evening Standard)

• Current Psychedelic Therapies Use Flawed Models of the Mind – It’s Time for Relational Therapy (Healing Maps)

• Mind Cure Health Halts All Psychedelic Business Activity (Psychedelic Spotlight)

• Are drug wars protection rackets? (Drug WarRant)

• Microdosing Is On The Rise But Is It Healthy? (The Dales Report)

• Terence McKenna’s Anarchic Psychedelic Religion (JSTOR Daily)

• Coming of Age in the Psychedelic Sixties (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.4.22

Cannabis

• Maryland House Advances Cannabis Legalization Bills (High Times)

• D.C. Lawmakers Approve Ban On Pre-Employment Marijuana Testing For Most Workers (Marijuana Moment)

• Where does Biden’s Supreme Court nominee stand on marijuana legalization? Here’s what we found (Leafly)

• Medicinal Cannabis Flower Sales Begin In Minnesota (High Times)

• Virginia House Committee Kills Bill To Begin Marijuana Sales This Year (Marijuana Moment)

• Rhode Island Lawmakers Introduce Cannabis Legalization Bill (High Times)

• NCAA Moves To Lower Marijuana Penalties For Student Athletes And Increase THC Threshold In Drug Tests (Marijuana Moment)

• Nebraska Medical Cannabis Bill Fizzles in Committee (High Times)

• Get ready for the Northeast to become cannabis country (Politico)

• France Moves to Begin Cultivating Medical Cannabis (High Times)

• Virginia lawmakers cracking down on cannabis compound Delta-8 due to safety concerns (WAVY)

• South Dakota House Rejects Marijuana Legalization Bill That Was Temporarily Revived In ‘Smoke Out’ Vote (Marijuana Moment)

• Ecuador Kicks Off Medical Cannabis Production (High Times)

• Washington state to require pesticide testing for adult-use cannabis products (Marijuana Business Daily)

• Ohio Lawmakers Advance Bill To Allow Medical Cannabis for Autism (High Times)

• Confusion over CBD for Children (Drug WarRant)

• Pennsylvania Senate Committee Holds Second Marijuana Legalization Hearing As Reform Bill Is Drafted (Marijuana Moment)

• Georgia Lawmakers Consider Bill to Expand Medical Pot Program (High Times)

LSD

• Landmark trial compares LSD and psilocybin trips, finds few differences (New Atlas)

• Mystical experiences might bridge the gap between LSD-induced “madness” and healing (PsyPost)

Magic Mushrooms

• Colorado may be the next state to decriminalize ‘magic’ mushrooms (The Durango Herald)

• Terminal cancer patient denied magic mushrooms after Health Canada rule change (CBC)

• Psilocybin Leaps Ahead of Other Psychedelics in Trials and Studies (Lucid News)

• The Plan to Reschedule Psilocybin at the UN (TalkingDrugs)

• 'We need emergency access': 82 Canadian professionals request psilocybin for therapy training (Vancouver Sun)

• Oregonians more interested in taking psilocybin for well-being than depression or anxiety (OPB)

• How Will Oregon Teach and Train Psilocybin Healers? (Filter)

• Magic mushrooms, psilocybin and microdosing: Growing trend draws e-vendors, scientists (CBC)

MDMA

• Can MDMA Help Heal Grief? (Lucid News)

5-MeO-DMT

• Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So (Forbes)

Iboga

• MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program (PR Newswire)

Novel Psychoactive Substances

• PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma (Psilocybin Alpha)

Synthetic Cannabinoids

• CBP Officers and Scientists Identify Two New Synthetic Cannabinoid Analogues (Homeland Security Today)

Ketamine

• Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit (Dr. Bronner's)

• Ketamine Could Treat Alcohol Use Disorder, Study Shows (Lucid News)

• Dying to Stay Alive: A Ketamine Disaster (Mad in America)

• Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease (Yale Daily News)

• Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests (Brain and Behavior Research Foundation)

Miscellaneous

• It’s Time to Start Studying the Downside of Psychedelics (VICE)

• Utah Psychedelics And Mental Health Bill Heads To Governor’s Desk After Senate Approval (Marijuana Moment)

• In Oregon, Psychedelics Regulators Confront Conflicts of Interest (VICE)

• More People Are Microdosing for Mental Health. But Does It Work? (The New York Times)

• The Need for an International Psychedelic Religious Survey (Psychedelics Today)

• Psychedelic Therapeutics Market May Receive Federal Approval Before Marijuana Does (MarketWatch)

• Staring into the Abyss: Examining Venezuela’s Drug Policies (TalkingDrugs)

• Global Survey: Some Microdosing Individuals Have Altered Psychiatric Drug Dosage (Psychiatry Advisor)

• How Psychedelics Will Impact Mainstream Product Development (Yahoo!)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.29.21

Cannabis

• With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)

• Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)

• Why did Texas ban Delta-8? (Popular Science)

• Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)

• California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)

• State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)

• The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)

• Cannabis is one industry that's actually coming out of Covid even stronger (CNN)

• South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

• New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)

• Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)

• Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)

• Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)

• Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)

• Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)

LSD

• Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)

Magic Mushrooms

• Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)

• Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)

• Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)

• Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)

• More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)

• MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

• Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)

MDMA

• No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)

• MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)

Ayahuasca

• Des Moines church fights IRS over ‘religious’ use of hallucinogenic drug (Iowa Capital Dispatch)

5-MeO-DMT

• Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)

Novel Psychoactive Substances

• Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)

• Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)

• Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)

• Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)

Synthetic Cannabinoids

• The Dangers of 'Spice' and Other Synthetic Cannabinoids (Discover Magazine)

Ketamine

• European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)

• Cocaine, ketamine use on the rise: survey (PerthNow)

• Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)

• MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)

Miscellaneous

• Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)

• Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)

• Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)

• Addressing Abuse in Psychedelic Spaces (Psychedelics Today)

• North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)

• Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)

• Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)

• How Gender Affects the Way We Use Drugs (TalkingDrugs)

• DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)

• MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)

• Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)

• Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)

• Psychedelic Research Beyond Depression & Trauma (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.1.21

Cannabis

• Bill To Federally Legalize Marijuana Approved By Key House Committee (Marijuana Moment)

• Marijuana Arrests Fall Precipitously Nationwide in 2020 (NORML)

• California Governor Signs Bill To Allow Medical Marijuana Use In Hospitals For Severely Ill Patients (Marijuana Moment)

• Kansas City, MO: City Council Approves Measure Eliminating Pre-Employment Marijuana Testing for Most City Workers (NORML)

• Hundreds prescribed medical cannabis in bid to persuade lawmakers to offer it on NHS (Mirror)

• Mississippi Lawmakers Move to Implement Medical Cannabis Legislation (High Times)

• Los Angeles: District Attorney to Vacate Some 60,000 Marijuana Convictions (NORML)

• DEA Still Insists Marijuana Has No 'Accepted Medical Use' (Reason)

• The Making Of New York’s $150 Million ‘Cannabis Campus’ (Forbes)

• What are they smoking? CNN says study found cannabis could double heart attack risk – but did it? (The Cannigma)

• Pennsylvania Lawmakers Unveil Marijuana Legalization Bill With Focus On Social Equity (Marijuana Moment)

• Your Smartphone Can Tell If You’re High On Marijuana, Study Finds (Forbes)

• Nebraska Advocates Launch Signature Drive For 2022 Medical Marijuana Ballot Measures (Marijuana Moment)

• Curbside Recreational Weed Pickups End in Massachusetts (High Times)

• Federal Grant Approved to Study Medical Marijuana Impact in Arkansas (High Times)

LSD

• Cannot treat LSD and its carrier material as separate, says court Cannot treat LSD and its carrier material as separate, says court (The Times of India)

Magic Mushrooms

• From Sugar To Psychedelics: The European Companies Testing Biosynthetic Psilocybin In Humans (Forbes)

• Decrim California’s Plan to Regulate Psilocybin Via Ballot (Truffle Report)

• My Bipolar Mother's Quest For Relief With Magic Mushrooms (VICE)

• Oregon Board to Vote on Psilocybin Facilitator Program (Truffle Report)

• Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing (Psilocybin Alpha)

MDMA

• MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy (Psilocybin Alpha)

• Levels of MDMA and cocaine in river running through Glastonbury Festival site so high they could harm wildlife, scientists say (Independent.ie)

• Police urging parents to inspect Halloween candy after ecstasy discovered (Fox News)

• MDMA: A Catalyst for ED-PTSD Treatment (Psychedelic Science Review)

DMT

• Companies Compete to Create DMT Therapies (Lucid News)

Ayahuasca

• Will Smith Embarked On A Dozen Ayahuasca Rituals In Peru After Denzel Washington Sold Him On The “F*ck It 50s” (BroBible)

• Man charged after alleged sex assault linked to ayahuasca ceremony (CBC)

Novel Psychoactive Substances

• Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders (Psilocybin Alpha)

• BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders (Psilocybin Alpha)

• Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates (Psilocybin Alpha)

Ketamine

• Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate (News-Medical.net)

Miscellaneous

• Ending The Silence Around Psychedelic Therapy Abuse (Mad in America)

• Can Psychedelic Drugs Treat Physical Pain? (Scientific American)

• Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre (Psilocybin Alpha)

• Seattle City Council Takes First Step Toward Decriminalizing Psychedelic Plants And Fungi (Marijuana Moment)

• Florida Lawmakers Introduce Bill to Study Psychedelics (Truffle Report)

• DoubleBlind Magazine's First-Ever Psychedelics Billboard Campaign Is Turning New Yorkers On To Plant Medicine (Benzinga)

• Psychedelics might reduce internalized shame and complex trauma symptoms in those with a history of childhood abuse (PsyPost)

• Massachusetts Lawmakers Discuss Drug Decriminalization And Safe Injection Sites At Hearing (Marijuana Moment)

• Bay Staters for Natural Medicine on Easthampton Decrim (Truffle Report)

• ‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health (The Guardian)

• Are Psychedelic Drugs the Answer to Veterans’ PTSD? (Men's Health)

• 19-Year-Old New Hampshire Lawmaker Prepares Bills To Decriminalize Psilocybin And All Drugs (Marijuana Moment)

• Elon Musk Embraces Potential of Psychedelics at CodeCon (High Times)

• How Effective Is Fireside Project's Psychedelic Hotline? New Study Aims To Find Out (Forbes)

• Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality (Psychedelics Today)

• Pantheistic Insights: Vegetarianism in Psychedelic Culture (The Oak Tree Review)

• 'The End In Mind' Conference Answers Questions About Psychedelics For End-Of-Life Patients (Forbes)

• Community Alert! Arrests and Encounters with Law Enforcement are Increasing (Chacruna)

• People Are Facing Legal Repercussions for Serving Plant Medicine — Here’s What’s Being Done to Help Them (DoubleBlind)

• Does psychedelic microdosing work? Brain study will be the real acid test (The New Daily)

• Psychedelia in the Soviet Union (Reality Sandwich)

• The Mystical Experience Defines Psychedelics (Lucid News)

• Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases (PR Newswire)

• Why Psychedelic Therapy Needs Best Practices & How to Get There (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.30.21

Cannabis

• Barcelona cannabis clubs face closure in new legal setback (The Guardian)

• Black People in Colorado Are Still Arrested for Weed Twice as Much as Everyone Else (MERRY JANE)

• Epilepsy Patients Who Use ‘Artisanal CBD’ Have Higher Quality Of Life, Study Finds (Marijuana Moment)

• Is medical cannabis really a magic bullet? (The Guardian)

• New Study Finds California Cannabis Farms Irrigating with Groundwater May Affect Stream Flows (Sierra Sun Times)

• Ohio Lawmakers Officially File Marijuana Legalization Bill In Historic First For The State (Marijuana Moment)

• You Can Get a Free Eighth of Weed For Getting Vaccinated in SF (Broke Ass Stuart)

• California Senator Seeks Federal Clarification On Medical Marijuana Use In Hospitals (Marijuana Moment)

• How Mexico Has Legalized But Still Not Regulated Cannabis (Filter)

• Why cannabis is still a banned Olympics substance (BBC)

• Pop Star Lorde Smokes Weed Out of DIY Fennel Bulb Bong in New Music Video (MERRY JANE)

• Study: Marijuana Legalization Laws Don’t Undermine Tobacco Smoking Prevention Efforts (NORML)

LSD

• New study sheds light on how LSD’s entropic effects on the brain impact language production (PsyPost)

Magic Mushrooms

• Oregon State Board Says Psilocybin Is Effective At Treating Certain Mental Health Condition (Marijuana Moment)

• Psilocybin appears to alter how the brain integrates tactile sensory inputs (PsyPost)

• TheraPsil Launches New Campaign for Psilocybin Access (Truffle Report)

• Why Don’t Magic Mushroom Spores Contain Psilocybin? (Psychedelic Science Review)

• Psilocybe Cyanescens: A Mycologist’s Guide to Wavy Caps (DoubleBlind)

• Health Canada dragging feet on approving magic mushrooms for therapeutic use, patients and advocates say (CBC)

• More Details on the Psilocybin Mushroom Bluing Reaction (Psychedelic Science Review)

• Florida researchers work to understand power of psychedelics to treat mental illness (ABC7 Southwest Florida)

MDMA

• MDMA-assisted cognitive-behavioral therapy may help couples overcome PTSD (PsyPost)

• MDMA might be able to improve your already loving relationship, suggests Yale ethicist (KCRW)

• 'You Can Forgive Yourself:' Molly Helps Vets with PTSD, New Study Says (Military.com)

• How to reduce your risk of harm when taking MDMA and ecstasy (Metro)

• 2 Music Playlists For Therapeutic MDMA Sessions (Maps of the Mind)

DMT

• MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT (Psilocybin Alpha)

Ayahuasca

• Psychedelics, Religion, and the DEA’s Quest for Soul (Psychedelics Today)

• Drinking Psychedelic Brew Ayahuasca May Help Drug And Alcohol Addicts Quit (IFLScience)

• Joe Rogan And Comedian Ari Shaffir Discuss Tripping Balls On Ayahuasca (BroBible)

Iboga

• Gabon’s government is tripping for a psychedelic plant (Financial Times)

• Ibogaine: The Psychedelic Drug That Could Fight Addiction (Discover Magazine)

• MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research (Psilocybin Alpha)

Synthetic Cannabinoids

• Synthetic cannabis warning: Second death from 'dangerous' batch in Taranaki (New Zealand Herald)

Nitrous Oxide

• Mindful Use of Nitrous Oxide: How to be a Connoisseur of Getting High (Maps of the Mind)

Ketamine

• Tucson wrongful death lawsuit questions ketamine usage (ABC15 Arizona)

• Ketamine Therapy and Addiction Risk Management: Part III (Truffle Report)

• Understanding Where Ketamine Comes From (Healing Maps)

Miscellaneous

• House Rejects AOC Amendment To Promote Research Into Psychedelics’ Medical Benefits (Marijuana Moment)

• $40m psychedelic medicine institute launches in Melbourne (The Sydney Morning Herald)

• Psychedelic trips could soon be part of therapy — here’s what those sessions will look like (CNBC)

• How TikTok's Viral Psychedelic Water Might Affect Your Mood (Mashed)

• Philippines President Rodrigo Duterte Is About to Be Investigated for All the Drug Dealers He's Killed (MERRY JANE)

• Controversies Around California’s Psychedelic Decriminalization Law Senate Bill 519 (Chacruna)

• Judaism’s Psychedelic Renaissance (Tablet Magazine)

• Grandparents of Psychedelics Ann and Sasha Shulgin Honored by Friends and Fellow Researchers (Lucid News)

• Corrections to Misinformation Being Spread about MAPS and IPCI (Dr. Bronner's)

• “Undoing Drugs”—Maia Szalavitz’s Profound History of Harm Reduction (Filter)

• The Graeme Carl Scale: 5 Levels of a Psychedelic Experience (Maps of the Mind)

• Mestizo Identity and Decolonial Psychedelic Futures (Chacruna)

• Fireside Project for Psychedelic Peer Support: An Update (Truffle Report)

• Veteran Psychedelics Advocate/Attorney Launches New Venture Capital Firm (Forbes)

• Highlight on Life Clips, AI, and Speech Based Technology in Psychedelic Science (Dark Matters)

• The Lilly Psychonautic Centre – A Vision from the Future (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.